Floatz logo

Therapeutic Asset Ratings

1,179 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Infliximab
Lung Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Endometrial Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Head And Neck Squamous Cell Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Ovarian Clear Cell Adenocarcinoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Chondrosarcoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Ovarian Serous Adenocarcinoma
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Ovarian Cancer
M.D. Anderson Cancer CenterP1CC (43)
IPN 60090
Uterine Corpus Cancer
M.D. Anderson Cancer CenterP1CC (43)
jv-213
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1CC (43)
jv-213
Lymphoma
M.D. Anderson Cancer CenterP1CC (43)
LENVATINIB
Adenocarcinoma
M.D. Anderson Cancer CenterP1CC (43)
Lisaftoclax
Chronic Myeloid Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Lisaftoclax
T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Lisaftoclax
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer CenterP1CC (43)
Lonafarnib
Supratentorial Cancer
M.D. Anderson Cancer CenterP1CC (43)
Loperamide
Colitis
M.D. Anderson Cancer CenterP1CC (43)
Loperamide
Uterine Cancer
M.D. Anderson Cancer CenterP1CC (43)
Mosunetuzumab
B-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Neratinib
Amyotrophic Lateral Sclerosis Type 19
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Malignant Leptomeningeal Tumor
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Meningeal Melanocytoma
M.D. Anderson Cancer CenterP1CC (43)
Obx-115
Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Olaparib
Digestive System Cancer
M.D. Anderson Cancer CenterP1CC (43)
Olaparib
Male Reproductive Organ Cancer
M.D. Anderson Cancer CenterP1CC (43)
Showing 926 to 950 of 1,179 assets
PreviousPage 38 of 48Next